Bradykinin is an important autacoid produced in the kidney, regulating both renal function and blood pressure. In vivo studies in anesthetized rabbits, revealed that BK induced diuresis (UV), natriuresis (U NaV) and was not associated with renal hemodynamic changes. These diuretic and natriuretic effects were blocked by the BK-B 2 antagonist HOE-140. BK also inhibits vasopressin (AVP)-stimulated water flow ( L p) in microperfused rabbit cortical collecting ducts (rCCD), in a concentration-dependent fashion, consistent with its in vivo diuretic effects. BK-B 1 antagonist Leu 8-des-Arg 9-BK did not alter the effect of BK on L p, but HOE-140 completely blocked the inhibitory effects of BK on L p. While BK did not increase [Ca 2+] i in fura-2 loaded freshly microdissected rCCD, BK increased [Ca 2+] i in immortalized cultured rCCD cells demonstrating different signaling mechanisms are activated by BK in microdissected versus cultured rCCD. In microperfused rCCD, neither the protein kinase C inhibitor staurosporine nor the phospholipase C (PLC) inhibitor U-73,122 attenuated the BK response arguing against activation of PLC/PKC by BK in rCCD. We conclude: (1) BK induces UV and U NaV by a BK-B 2 receptor; (2) BK inhibits AVP-stimulated L p by a BK-B 2 receptor suggesting that its effects on L p are not via a PLC/PKC; (3) finally, BK raises [Ca 2+] i in rCCD cells by a BK-B 2 receptor mechanism.